283 related articles for article (PubMed ID: 29446249)
1. Serological responses to revaccination against HBV in HIV-positive patients born in the era of nationwide neonatal HBV vaccination.
Huang YC; Hsieh SM; Sheng WH; Huang YS; Lin KY; Chen GJ; Yang SP; Liu WC; Su YC; Sun HY; Hung CC; Chang SC
Liver Int; 2018 Nov; 38(11):1920-1929. PubMed ID: 29446249
[TBL] [Abstract][Full Text] [Related]
2. Evolution of Hepatitis B Virus (HBV) Serologic Markers Among Antiretroviral-Naive Young People Living With Human Immunodeficiency Virus Who Had Undergone Neonatal HBV Vaccination and Initiated Antiretroviral Therapy.
Huang YC; Sun HY; Sheng WH; Hsieh SM; Huang SH; Chen GJ; Liu WD; Chang SY; Su YC; Su LH; Liu WC; Hung CC
Clin Infect Dis; 2022 Sep; 75(5):882-889. PubMed ID: 34893815
[TBL] [Abstract][Full Text] [Related]
3. Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV: A Randomized Clinical Trial.
Vargas JI; Jensen D; Martínez F; Sarmiento V; Peirano F; Acuña P; Provoste F; Bustos V; Cornejo F; Fuster A; Acuña M; Fuster F; Soto S; Estay D; Jensen W; Ahumada R; Arab JP; Soza A; Fuster F
JAMA Netw Open; 2021 Aug; 4(8):e2120929. PubMed ID: 34424307
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan.
Lin JJ; Lin KY; Tang HJ; Lin SP; Lee YC; Liu CE; Huang YS; Wang NC; Li CW; Ko WC; Yang HJ; Lee YT; Hung CC;
J Microbiol Immunol Infect; 2021 Apr; 54(2):228-237. PubMed ID: 31708481
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
[TBL] [Abstract][Full Text] [Related]
6. Persistence of Hepatitis B Immunity Following 3-dose Infant Primary Series in HIV-infected Thai Adolescents and Immunologic Response to Revaccination.
Lapphra K; Angkhananukit P; Saihongthong S; Phongsamart W; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
Pediatr Infect Dis J; 2017 Sep; 36(9):863-868. PubMed ID: 28419007
[TBL] [Abstract][Full Text] [Related]
7. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
[TBL] [Abstract][Full Text] [Related]
8. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among non-responsive adults: a 4-year of follow-up study].
Zhang L; Yan BY; Lyu JJ; Liu JY; Feng Y; Wu WL; Cao CZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):497-502. PubMed ID: 27256728
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.
Sun HY; Cheng CY; Lee NY; Yang CJ; Liang SH; Tsai MS; Ko WC; Liu WC; Wu PY; Wu CH; Lin HH; Hung CC
PLoS One; 2014; 9(2):e90194. PubMed ID: 24587275
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
[TBL] [Abstract][Full Text] [Related]
11. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
Chonwattana W; Raengsakulrach B; Holtz TH; Wasinrapee P; Tongtoyai J; Chaikummao S; Pattanasin S; McNicholl JM; van Griensven F; Curlin ME
Vaccine; 2016 Apr; 34(17):2044-50. PubMed ID: 26685092
[TBL] [Abstract][Full Text] [Related]
14. Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.
Piroth L; Launay O; Michel ML; Bourredjem A; Miailhes P; Ajana F; Chirouze C; Zucman D; Wendling MJ; Nazzal D; Carrat F; Rey D; Binquet C;
J Infect Dis; 2016 Jun; 213(11):1735-42. PubMed ID: 26768256
[TBL] [Abstract][Full Text] [Related]
15. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus prevalence and vaccine response in HIV-infected children and adolescents on combination antiretroviral therapy in Kigali, Rwanda.
Mutwa PR; Boer KR; Rusine JB; Muganga N; Tuyishimire D; Reiss P; Lange JM; Geelen SP
Pediatr Infect Dis J; 2013 Mar; 32(3):246-51. PubMed ID: 22976050
[TBL] [Abstract][Full Text] [Related]
17. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among low-responder infants following primary vaccination: 4-year of follow-up].
Lyu JJ; Yan BY; Liu JY; Feng Y; Wu WL; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ; Zhang L
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):490-495. PubMed ID: 28592091
[No Abstract] [Full Text] [Related]
18. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
[TBL] [Abstract][Full Text] [Related]
19. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
[TBL] [Abstract][Full Text] [Related]
20. [Matching study on immune response between single anti-HBc positivity and healthy adults after primary immunization and revaccination of hepatitis B vaccine].
Liu J; Lyu J; Yan B; Feng Y; Zhang L; Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Oct; 35(10):1091-4. PubMed ID: 25567010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
